Skip to main content

MOTS-c vs Semax

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

MOTS-c

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a mitochondrial-derived peptide that plays a key role in metabolic regulation and has emerged as a significant longevity research target.

Full details →

Semax

Semax is a synthetic peptide derived from ACTH (adrenocorticotropic hormone). Developed in Russia as a nootropic and neuroprotective agent.

Full details →

Side-by-Side Comparison

AspectMOTS-cSemax
Dose Range5 mg–10 mg300 mcg–600 mcg
FrequencyLess than daily2x daily
Cycle Length8–12 weeks2–4 weeks
Routesubcutaneousintranasal
MechanismActivates AMPK pathway, enhances glucose uptake in skeletal muscle, improves insulin sensitivity, and regulates mitochondrial function. Acts as a metabolic hormone affecting whole-body energy homeostasis.Enhances BDNF expression, modulates dopamine and serotonin systems, and provides neuroprotective effects. Increases attention, memory formation, and learning.
Typical DosageResearch protocols typically use 5-10mg administered subcutaneously several times per week. Optimal dosing not yet established.Intranasal: 200-600mcg 2-3 times daily. Higher doses (up to 1mg) used in clinical settings for stroke recovery.
AdministrationSubcutaneous injection. Often combined with exercise protocols as it enhances exercise capacity and metabolic adaptation.Primarily administered intranasally. N-Acetyl Semax Amidate (NASA) is a modified version with enhanced stability and potency.
Side EffectsLimited human data. Animal studies show good tolerability. May affect energy levels and exercise performance.Generally well-tolerated. May cause mild irritability or hair shedding in some users.
Best For

Key Differences

Key Studies

Ready to Learn More?